Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Elecsys Anti-HCV II (08837031190)

K-Number: K221693 · 2023-01-04

Decision Date2023-01-04
Product CodeMZO
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Elecsys Anti-HCV II (08837031190) is a medical device manufactured by Roche Diagnostics. It received FDA 510(k) clearance on 2023-01-04 under approval number K221693. The device is classified under product code MZO. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Elecsys Anti-HCV II (08837031190)?

Elecsys Anti-HCV II (08837031190) is a medical device that received FDA 510(k) clearance on 2023-01-04. It is manufactured by Roche Diagnostics. The 510(k) number is K221693.

When was Elecsys Anti-HCV II (08837031190) approved by the FDA?

Elecsys Anti-HCV II (08837031190) received FDA 510(k) clearance on 2023-01-04, under approval number K221693.

What company makes Elecsys Anti-HCV II (08837031190)?

Elecsys Anti-HCV II (08837031190) is manufactured by Roche Diagnostics.

What is the FDA product code for Elecsys Anti-HCV II (08837031190)?

The FDA product code for Elecsys Anti-HCV II (08837031190) is MZO.

Other Devices by Roche Diagnostics

View all 70 devices →

Related Devices (Code: MZO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.